Suppr超能文献

口服避孕药对大鼠脑和垂体β-内啡肽的影响。

Effect of oral contraceptives on the rat brain and pituitary beta-endorphin.

作者信息

Tejwani G A, Vaswani K K, Barbacci J C, Richard C W, Bianchine J R

出版信息

Life Sci. 1983;33 Suppl 1:519-22. doi: 10.1016/0024-3205(83)90555-6.

Abstract

The purpose of this study was to investigate the effect of oral administration of progesterone (15 micrograms norethindrone, NE) in presence and absence of estradiol (1 microgram ethinyl estradiol, EE2) on the CNS levels of beta-endorphin like immunoreactivity (beta-EI) in female rats. In acute study (5 days), NE alone did not change beta-EI significantly in pituitary. NE and EE2 together decreased beta-EI by 37% (47% at 10X dose). In chronic study (7 weeks), 2NE had no significant effect on pituitary beta-EI, however, NE and EE2 together at 10X dose decreased it by 14%. In the hypothalamus, NE alone or in presence of EE2 had no significant effect on beta-EI, but 10X dose of NE+ EE2 caused 50 and 76% decrease in beta-EI in acute and chronic study. Striatum was the only tissue where NE alone caused a decrease of 82% in beta-EI when given acutely and 52% when given chronically. EE2 had some protective effect on this decrease since when given together (NE+EE2) the decrease in beta-EI was 21% in acute and 43% in chronic study. Thus our results, along with other studies on the regulation of gonadotropin levels by opioids, suggest that oral contraceptives alter the level of beta-EI and in turn may regulate the release of gonadotropins. Morphine and endogenous opioids have been shown to decrease gonadotropin secretion in various species including humans, apparently by suppressing the release of LH-RH from the hypothalamus (1-5). The opiate antagonist naloxone not only causes up to 10-fold increase in the secretion of gonadotropins (1,3, 6-9) but also opposes the negative feedback effect of steroids on the hypothalamic-pituitary-gonadotropin axis (8), suggesting a regulatory interaction between the endogenous opioids, gonadotropins and gonadal steroids. Like ACTH, the secretion of beta-endorphin is inhibited by glucocorticoids (10). Naloxone induced release of LH is facilitated by estradiol in humans (11) suggesting an antagonistic effect of estradiol on the endogenous opioids. beta-endorphin may play a significant role in neurochemical mechanisms of gonadotropin release in the human menstrual cycle. A preovulatory increase of beta-endorphin in serum occurs 2 days prior to LH surge and a postovulatory decrease in beta-endorphin occurs 5 days later.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

本研究的目的是调查在有和没有雌二醇(1微克乙炔雌二醇,EE2)存在的情况下,口服孕酮(15微克炔诺酮,NE)对雌性大鼠中枢神经系统中β-内啡肽样免疫反应性(β-EI)水平的影响。在急性研究(5天)中,单独使用NE对垂体中的β-EI没有显著影响。NE和EE2共同作用使β-EI降低了37%(10倍剂量时为47%)。在慢性研究(7周)中,2NE对垂体β-EI没有显著影响,然而,10倍剂量的NE和EE2共同作用使其降低了14%。在丘脑中,单独使用NE或在有EE2存在的情况下对β-EI没有显著影响,但在急性和慢性研究中,10倍剂量的NE + EE2导致β-EI分别降低了50%和76%。纹状体是唯一在急性给药时单独使用NE会使β-EI降低82%、慢性给药时降低52%的组织。EE2对这种降低有一定的保护作用,因为当一起给药(NE + EE2)时,急性研究中β-EI的降低为21%,慢性研究中为43%。因此,我们的结果以及其他关于阿片类物质对促性腺激素水平调节的研究表明,口服避孕药会改变β-EI的水平,进而可能调节促性腺激素的释放。吗啡和内源性阿片类物质已被证明在包括人类在内的各种物种中会降低促性腺激素的分泌,显然是通过抑制下丘脑释放促黄体生成素释放激素(LH-RH)(1 - 5)。阿片类拮抗剂纳洛酮不仅会使促性腺激素的分泌增加高达10倍(1,3,6 - 9),还会对抗类固醇对下丘脑 - 垂体 - 促性腺激素轴的负反馈作用(8),这表明内源性阿片类物质、促性腺激素和性腺类固醇之间存在调节相互作用。与促肾上腺皮质激素一样,β-内啡肽的分泌受到糖皮质激素的抑制(10)。在人类中,雌二醇促进纳洛酮诱导的促黄体生成素释放(11),这表明雌二醇对内源性阿片类物质有拮抗作用。β-内啡肽可能在人类月经周期中促性腺激素释放的神经化学机制中起重要作用。血清中β-内啡肽在促黄体生成素高峰前2天出现排卵前升高,排卵后5天出现β-内啡肽降低。(摘要截断于400字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验